Neuregulin
Neuregulin[edit]

Neuregulin is a family of proteins involved in cell-cell signaling, particularly in the development of the nervous system and the heart. Neuregulins are part of the epidermal growth factor (EGF) family and play a crucial role in the regulation of cell proliferation, differentiation, and survival.
Structure[edit]
Neuregulins are characterized by the presence of an epidermal growth factor-like domain, which is essential for their interaction with the ErbB family of receptor tyrosine kinases. The structure of neuregulin includes several domains that contribute to its function, including an immunoglobulin-like domain, a transmembrane domain, and a cytoplasmic tail.
Function[edit]
Neuregulins are involved in a variety of biological processes:
- Nervous System Development: Neuregulins are critical for the development of the peripheral nervous system, where they promote the formation and maintenance of Schwann cells.
- Cardiac Development: In the heart, neuregulins are essential for the development of cardiomyocytes and the formation of the heart valves.
- Synaptic Plasticity: Neuregulins play a role in the modulation of synaptic plasticity and are involved in the regulation of neurotransmitter release.
Mechanism of Action[edit]
Neuregulins exert their effects by binding to the ErbB family of receptors, which includes ErbB2, ErbB3, and ErbB4. Upon binding, these receptors dimerize and activate intracellular signaling pathways such as the PI3K/AKT pathway and the MAPK/ERK pathway, leading to various cellular responses.
Clinical Significance[edit]
Neuregulins have been implicated in several diseases:
- Cancer: Abnormal neuregulin signaling can contribute to the development of certain types of cancer, including breast cancer and glioblastoma.
- Schizophrenia: Alterations in neuregulin signaling have been associated with schizophrenia, suggesting a role in neuropsychiatric disorders.
- Heart Failure: Neuregulin therapy is being explored as a potential treatment for heart failure, due to its role in cardiac repair and regeneration.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian